Effect of glutathione peroxidase mimic ebselen (PZ51) on endothelium and vascular structure of stroke‐prone spontaneously hypertensive rats

References

• Suzuki H., DeLano F. A., Parks D. A., Jamshidi N., Granger D. N., Ishii H., et al. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA 1998; 95: 4754–4759
   PubMed Web of Science ®Google Scholar
• Suzuki H., Swei A., Zweifach B. W., Schmid‐Schonbein G. W. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: Hydroethidine microfluorography. Hypertension 1995; 25: 1083–1089
   PubMed Web of Science ®Google Scholar
• Russo C., Olivieri O., Girelli D., Faccini G., Zenari M., Lombardi S., et al. Anti‐oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertension 1998; 16: 1267–1271
   PubMed Web of Science ®Google Scholar
• Mihailovic M. B., Avramovic D. M., Jovanovic I. B., Pesut O. J., Matic D. P., Stojanov V. J. Blood and plasma selenium levels and GSH‐PX activities in patients with arterial hypertension and chronic heart disease. J Environ Pathol Toxicol Oncol 1998; 17: 285–289
   Google Scholar
• Hattori R., Inoue R., Sase K., Eizawa H., Kosuga K., Aoyama T., et al. Preferential inhibition of inducible nitric oxide synthase by ebselen. Eur J Pharmacol 1994; 267: R1–2
   PubMed Web of Science ®Google Scholar
• Masumoto H., Sies H. The reaction of ebselen with peroxynitrite. Chem Res Toxicol 1996; 9: 262–267
   PubMed Web of Science ®Google Scholar
• Hideaki I., David I. G., Hiroyuki M., Iseavall M. M. Antioxidant ebselen reduces oxidative damage in focal cerebral ischemia. Free Rad Biol Med 2003; 34: 56–63
   Google Scholar
• Dawson D. A., Masayasu H., Graham D. I., Macrae I. M. The neuroprotective efficacy of ebselen (a glutathione mimic) on brain damage induced by transient focal cerebral ischaemia in the rat. Neurosci Lett 1995; 185: 65–69
   PubMed Web of Science ®Google Scholar
• Ogawa A., Yoshimoto T., Kikuchi H., Sano K., Saito I., Yamaguchi T., et al. Ebselen in acute middle cerebral artery occlusion: A placebo‐controlled, double‐blind clinical trial. Cerebrovasc Dis 1999; 9: 112–118
   PubMed Web of Science ®Google Scholar
• Maulik N., Yoshida T., Das D. K. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Rad Biol Med 1998; 24: 869–875
   PubMed Web of Science ®Google Scholar
• Takasago T., Peters E. E., Graham D. I., Masayasu H., Macrae I. M. Neuroprotective efficacy of ebselen, an antioxidant with anti‐inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. Br J Pharmacol 1997; 122: 1251–1256
   PubMed Web of Science ®Google Scholar
• Namura S., Nagata I., Takami S., Masayasu H., Kikuchi H. Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke 2001; 32: 1906–1911
   PubMed Web of Science ®Google Scholar
• Tracey W. R., Tse J., Carter G. Lipopolysaccharide‐induce changes in plasma nitrite and nitrate concentrations in rat and mice: Pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 1995; 272: 1011–1015
   PubMed Web of Science ®Google Scholar
• Li L., Shen Y‐M., Yang X‐S., Wu W‐L., Wang B‐G., Chen Z‐H., et al. Effect of spiramine T on antioxidant enzymatic activities and nitric oxide production in cerebral ischemia‐reperfusion gerbils. Brain Res 2002; 944: 205–209
   PubMed Web of Science ®Google Scholar
• Kato N., Yanaka K., Nagase S., Hirayama A., Nose T. The antioxidant EPC‐K1 ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischaemia. Acta Neurochir 2003; 145: 489–493
   Google Scholar
• The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high‐risk patients. N Eng J Med 2000; 342: 154–160
   PubMed Web of Science ®Google Scholar
• Stephens N. G., Parsons A., Schofield P. M., Kelly F., Cheeseman K., Mitchinson M. J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781–786
   PubMed Web of Science ®Google Scholar
• Kok F. J., van Poppel G., Melse J., Verheul E., Schouten E. G., Kruyssen D. H., et al. Do antioxidants and polyunsaturated fatty acids have a combined association with coronary atherosclerosis. Atherosclerosis 1991; 86: 85–90
   Google Scholar
• Ichikawa S., Omura K., Katayama T., Okamura N., Ohtsuka T., Ishibashi S., et al. Inhibition of superoxide anion production in guinea pig polymorphonuclear leukocytes by a seleno‐organic compound, ebselen. J Pharmacobio‐dyn 1987; 10: 595–597
   Google Scholar
• Guzik T. J., West N. E. J., Pillai R., Taggart D. P., Channon K. M. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension 2002; 39: 1088–1094
   PubMed Web of Science ®Google Scholar
• Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–358
   PubMed Web of Science ®Google Scholar
• Yasunari K., Maeda K., Nakamura M., Yoshikawa J. Carvedilol inhibits pressure‐induced increase in oxidative stress in coronary smooth muscle cells. Hypertens Res 2002; 25: 419–425
   Google Scholar
• Tomas J. P., Geiger P. G., Girotti A. W. Lethal damage to endothelial cells by oxidized low density lipoprotein: Role of selenoperoxidases in cytoprotection against lipid hydroperoxide‐ and iron‐mediated reactions. J Lipid Res 1993; 34: 479–489
   Google Scholar
• Liao J. K., Shin W. S., Lee W. Y., Clark S. L. Oxidized low‐density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 319–324
   PubMed Web of Science ®Google Scholar
• Fukuo K., Yang J., Suzuki T., Kaimoto T., Takemura Y., Yasuda O., et al. Nifedipine upregulates manganese superoxide dismutase expression in vascular smooth muscle cells via endothelial cell‐dependent pathways. Hypertens Res 2003; 26: 503–508
   PubMed Web of Science ®Google Scholar
• Fukai T., Siegfried M. R., Ushio‐Fukai M., Cheng Y., Kojda G., Harrison D. G. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 2000; 105: 1631–1639
   PubMed Web of Science ®Google Scholar
• Bots M. L., Hoes A. W., Koudstaal P. J., Hofman A., Grobbee D. E. Common carotid intima‐media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997; 96: 1432–1437
   PubMed Web of Science ®Google Scholar
• Chambless L. E., Folsom A. R., Clegg L. X., Sharrett A. R., Shahar E., Nieto F. J., et al. Carotid wall thickness is predictive of incident clinical stroke: The Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000; 151: 478–487
   PubMed Web of Science ®Google Scholar
• Rao G. N., Lassegue B., Griendling K. K., Alexander R. W. Hydrogen peroxide stimulates transcription of c‐jun in vascular smooth muscle cells: Role of aracidonic acid. Oncogene 1993; 8: 2759–2764
   PubMedGoogle Scholar
• Eddie L. G., Victoria V., Ayad A. J. Role of reactive oxygen species in bradykinin‐induced mitogen‐activated protein kinase and c‐fos induction in vascular cells. Hypertension 2000; 35: 942–947
   Google Scholar
• Yamori Y., Igawa T., Kanbe T., Nara Y., Tagami M. Enhanced growth rate of cultured smooth muscle cells from spontaneously hypertensive rats. Heart Vessels 1988; 4: 94–99
   PubMedGoogle Scholar
• Intengan H. D., Schiffrin E. L. Vascular remodeling in hypertension: Roles of apoptosis, inflammation, and fivrosis. Hypertension 2001; 38((3 pt 2))581–587
   Google Scholar
• Yang D., Tan Z., Pan J. Y., Wang T. H. 17beta‐Estradiol inhibits vascular smooth muscle cell proliferation and c‐fos expression: Role of nitric oxide. Sheng Li Xue Bao 2002; 54: 17–22
   Google Scholar
• Ceriello A., Giugliano D., Quatraro A., Lefebvre P. J. Anti‐oxidants show anti‐hypertensive effect in diabetic and hypertensive subjects. Clin Sci 1991; 81: 739–742
   PubMed Web of Science ®Google Scholar
• Galley H. F., Thornton J., Howdle P. D., Walker B. E., Webster N. R. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci 1997; 92: 361–365
   PubMed Web of Science ®Google Scholar
• Meng S., Cason G. W., Gannon A. W., Racusen L. C., Manning R. D Jr. Oxidative stress in Dahl salt‐sensitive hypertension. Hypertension 2003; 41: 1346–1352
   PubMed Web of Science ®Google Scholar
• Park J. B., Touyz R. M., Chen X., Schiffrin E. L. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt‐loaded stroke‐prone spontaneously hypertensive rats. Am J Hypertens 2002; 15((1 Pt 1))78–84
   Google Scholar
• Noguchi T., Ikeda K., Sasaki Y., Yamamoto J., Seki J., Yamagata K., et al. Effect of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke‐prone spontaneously hypertensive rats. Hypertens Res 2001; 24((6))735–742
   Google Scholar
• Negishi H., Xu J. W., Ikeda K., Njelekela M., Nara Y., Yamori Y. Black and green tea polyphenols attenuate blood pressure increases in stroke‐prone spontaneously hypertensive rats. J Nutr 2004; 134: 38–42
   PubMed Web of Science ®Google Scholar
• Chen X., Touyz R. M., Park J. B., Schiffrin E. L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke‐prone SHR. Hypertension 2001; 38((3 Pt 2))606–611
   Google Scholar
• Gil‐Longo J., Fernandez‐Grandal D., Alvarez M., Sieira M., Orallo F. Study of in vivo and in vitro resting vasodilator NO tone in normotensive and genetically hypertensive rats. Eur J Pharmacol 1996; 310: 175–183
   PubMed Web of Science ®Google Scholar
• Miyashita F., Kawaguchi A., Sugimoto K., Kitoh Y., Tsutsumi H., Fujimura A. Failure of probucol to prolong survival in salt‐loaded stroke‐prone spontaneously hypertensive rats. Hypertens Res 2000; 23: 497–501
   Google Scholar